Ticker: KALV

Company: Carbylan Therapeutics, Inc.

Person: Benjamin L Palleiko, director, officer

Transaction date: April 16, 2026

Reporting date: April 20, 2026

Average share price: -17.939571176361273

Sold 10762.0 shares for 193065.67